Press Releases FluoGuide A/S

Equities

FLUO

DK0061123312

Market Closed - Nasdaq Stockholm Other stock markets 11:24:25 2024-05-24 am EDT			5-day change	1st Jan Change
48.65 ^SEK	+0.10%		-4.23%	-20.51%

Mar. 20	FluoGuide A/S Approves Board Changes	CI
Mar. 12	FluoGuide A/S Enters Collaboration Within Robot Assisted Head and Neck Cancer Surgery with Intuitive Surgical, Inc	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Minutes from Annual General Meeting in FluoGuide A/S	Mar. 20	AQ
Chief Financial Officer (CFO) Ole Larsen buys shares	Mar. 13	AQ
FluoGuide enters collaboration within robot assisted head and neck cancer surgery with Intuitive Surgical, a world leading robotic-assisted surgery company	Mar. 12	AQ
Notice of Annual General Meeting in FluoGuide A/S	Mar. 01	AQ
Fluoguide Q4 2023 - Bright prospects	Feb. 28	AQ
FluoGuide A/S publishes year-end and annual report for the fiscal year 2023	Feb. 28	AQ
FluoGuide A/S issues warrants to CFO	Feb. 23	AQ
FluoGuide provides strategic update and outlines development plans towards commercialization of FG001	Jan. 08	AQ
FluoGuide raises SEK 12 million through exercise of warrants	Dec. 11	AQ
Chief Development Officer (CDO) Grethe Nørskov Rasmussen sells shares	Dec. 09	AQ
FluoGuide raises SEK 12 million through exercise of warrants	Dec. 08	AQ
Fluoguide Q3 2023 - Spoilt for choice	Nov. 29	AQ
FluoGuide A/S publishes interim report for the period January – September 2023	Nov. 29	AQ
FluoGuide announces FG001 meets primary endpoint in phase llb trial in aggressive brain cancer	Nov. 13	AQ
FluoGuide confirms positive topline results from phase lla trial of FG001 in head & neck cancer at International Academy of Oral Oncology conference	Nov. 06	AQ
FluoGuide receives FDA Orphan Drug Designation for FG001 in high-grade glioma	23-10-03	AQ
FluoGuide receives Danish award for the best share price performance since IPO	23-09-08	AQ
Positive interim data from phase lla trial of FG001 in head & neck cancer presented as a case report at the World Molecular Imaging Congress in Prague	23-09-07	AQ
Fluoguide Q2 2023 - Closing in on high-impact catalysts	23-08-30	AQ
FluoGuide A/S publishes interim report for the period January – June 2023	23-08-30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases FluoGuide A/S

Equities

FLUO

DK0061123312

Press Releases

Filters